China Structural Ventricular Arrhythmias Registry
ConditionVentricular Arrythmia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChina National Center for Cardiovascular Diseases
About this trial
This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 centers in China,with clinical data to be abstracted from medical records ,and blood samples to be collected for finding promising risk indicators.The follow-up should be made every 6 mouths.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.
Disqualifiers
none
Trial population
In 10 major arrhythmia centers distributed in 6 areas in China, 2000 patients satisfying the inclusion criteria will be enrolled consecutively.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
sustained tachycardia/ ventricular fibrillation or sudden cardiac death
event of sustained ventricular tachycardia/ ventricular fibrillation or sudden cardiac death
Time frame
5 yearsSecondary outcomes
1
episodes of arrhythmia
record: type of arrhythmia, the amount of episodes, duration, unstable hemodynamics，treatment，
Time frame
5 years2
all-cause death
exclude accidents, like trauma, drowning.
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
China National Center for Cardiovascular Diseases
Lead sponsor
Renmin Hospital of Wuhan University
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Second Affiliated Hospital of Nanchang University
Collaborator
Sir Run Run Shaw Hospital
Collaborator
West China Hospital
Collaborator
Beijing Anzhen Hospital
Collaborator
General Hospital of Shenyang Military Region
Collaborator
Xuzhou Central Hospital
Collaborator
First Affiliated Hospital, Sun Yat-Sen University
Collaborator
Source ClinicalTrials.gov